Clinical trial
Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Treatment of Autoimmune Liver Disease
NCT04028869 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Treatment of Autoimmune Liver Disease
- Lead sponsor
- Beijing Ditan Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2018
- Completion date
- March 30, 2019
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune liver disease